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Topical 8-methoxypsoralen (8-MOP) was used to 
briefly provide free psoralen sufficient for marked cu-
t aneous photosensitization, but only a small dose of UV A 
w as delivered initially , in an effort to produce many 
monoadducts but few crosslinks. After ample time for 
c le arance of the remaining free psoralen a second UV A 
exposure was delivered. The second exposure should not 
have generated any additional monoadducts in the ab-
sence of free psoralen, but the remaining monoadducts 
could be converted to crosslinks. The observation of a 
p rolonged persistent UVA-photosensitive state caused 
by prior, very small doses of UV A given while free 8-
M OP w a s present strongly suggests that psoralen-DNA 
crosslinks per se initiate much of the phototoxic effect 
o f 8-MOP on skin, and that monoadducts induce much 
less acute inflammatory response. Because erythema 
w as s tudied as the end point, the data say nothing about 
relative contributions of monoadducts vs crosslinks in 
causing mutagenesis, hyperpigmentation, therapeutic or 
other cutaneous responses. Other explanations for the 
induced persistent photosensitive state are also possible, 
b ut less tenable or entirely hypothetical. 
Psoralen- UV A phototoxicity causes infla mmation in norma l 
sk in and is t herapeutic for a variety of skin diseases . We have 
studied t he phototox icity induced in human skin with 8-meth-
oxypsora len (8-MOP) , followed by administra t ion of 2 doses of 
UV A radiation given at 2 separate t imes. Such split irradiation 
in vi t ro can favor t he generation of psoralen-DNA crosslinks 
relative to monoadducts [1 - 3]. Split irradiation regimens as a 
way of favoring cross linking may be important for several 
reasons: 
1. P sora len and UV t reatment regimens favoring crosslink-
ing cause more prolonged inhibit ion of cell replication a nd 
DNA synt hesis in cell cul ture than regimens fa voring monoad-
ducts [ 4]. It is probable, alt hough controversial, that cross! inks 
may be more important t ha n monoadducts in the photochem-
otherapy of proliferat ive skin disease [5]. 
2. Monoadducts a re known to be mutagenic in bacteria [3], 
fungi [6] , yeasts [7], and in cul tured huma n fib roblasts [8], and 
may t herefo re have ca rcinogenic potent ia l in humans. Al t hough 
crosslinks may also be mutage nic, convers ion of monoadducts 
to crosslinks in certain bacterial stains resulted in decreased 
mutation frequ ency, while increasing lethality [9] . It has been 
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Abbreviations: 
MED: minimum erythema dose (that dose of UVA inducing uni -
form erythema wi th well -defined margins in the absence of 8-
MOP, read at 24 h) 
8-MOP: 8-methoxypsoralen 
MPD: minimum phototoxic dose 
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proposed by Hanawalt a nd coworkers [5,10] t hat t reatment 
regimens which favor generation of crosslinks relative to mon-
oadducts might be rela tively more therapeut ically effective wit h 
less long-te rm toxicity. 
Following in tercalation of t he psoralen molecule between 
adjacent base pairs on complementary DNA stra nds, absorp-
tion of a single photon can result in t he fo rmation of a cycle-
butane bond to one of t he pyrimidine bases, t hrough eit her t he 
pyrene or fura n ring of t he psoralen molecule, to result in a 
psoralen-DNA monoadduct. Absorption of a second photon by 
a suitably a ligned furan-side monoadduct may then resul t in 
an in te rstrand crosslink t hrough a pyrimidine base in t he 
opposing strand. 
Exposure conditions can be manipulated in several ways in 
order to favo r t he generation of eit her crosslinks or monoad-
ducts. 
1. The use of high radiation doses a nd low psoralen concen-
trations will tend to favo r crosslinking, which requires 2 pho-
tons per crosslinking psoralen molecule. Conversely, high pso r-
a len concent rations and low radiation doses favo r formation of 
monoadducts, which require only 1 photon per psoralen mon -
oadduct. 
2. Radiation in t he 380- to 400-nm ra nge favors t he genera-
t ion of monoadducts. These wavelengths are absorbed by inter-
ca lated psoralen result ing in psoralen -DNA monoadduct fo r-
mation. The furan-side monoadducts, on the other hand, absorb 
relatively poo rly in t his spectral region, and therefore t here is 
much less subsequent crosslinking than at wavelengths shorter 
t ha n 380 nm [4,11] . 
3. Pulsed lase r irradiation of less than 1 JJ-S duration favors 
monoadduct formation. It appears t hat a confor mational 
change must occur in DNA when a monoadduct is fi rst formed, 
before t he absorpt ion of a second photon can resul t in efficient 
crosslinking [1 2]. 
4. If irradiation is perfo rmed twice, once to fo rm ini t ial 
monoadducts under condi t ions of excess free psoralen, and 
t hen a second t ime afte r free psoralen has been removed or 
metabolized, maxima l conversion of t he ini t ia l monoadducts 
into crosslinks is possible, wi thout t he fo rmation of fur t her 
monoadducts . The limited period during which free psoralen is 
present in t he skin fo llowing eit her oral or topica l application 
may be used to achieve t his resul t experimentally, a nd is t he 
basis for the present study. 
Such an experiment involves t he foll owing assumpt ions: 
1. Cutaneous psoralen phototox icity as measured by delayed 
erythema is predomina nt ly t he result of formation of psoralen-
DNA crosslinks, whereas monoadducts cont ribute little to er-
ythemogenesis by comparison. 
2. r rradiation of psora len-treated skin binds psoralen to ce l-
lula r DNA mainly in t he fo rm of monoadducts when t here is 
excess free pso ralen present during irradiation. 
3. Some of t hese monoadducts may be converted to cross-
links by a later irradiation. If psoralen-DNA monoadducts are 
repaired more slowly t ha n t he clearance of unbound cutaneous 
psoralen, more crosslinks t han new monoadducts should be 
ge nerated by the second irradiation. T hus, a subphototox1c 
dose ofUV A given in t he presence of free psoralen should resul t 
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in mo re prolon ged p hotosensitiv ity to U V A t ha n t hat see n in 
skin treated wit h psora len a lon e. The degree a nd duration of 
pe rs istent photosens it ivity (measured as suscep t ibili t y to U V A-
induced de layed e rythem a) should depend upon (a ) the ratio of 
monoadducts to crosslinks formed by t he ini t ia l subphototoxic 
dose of U VA; (b) t he rate of repair of monoadducts which might 
lead to subsequent c rosslink fo rmation ; a nd (c) t he rate of 
repair of crosslinks. 
In t he prese nt st udy we demonstrate t he prolon ged , m a rked 
cuta neous photosens it iv ity to U V A caused by p rio r subery-
t hemoge nic exposures in t h e prese nce of 8-MOP. 
MATE RIALS AN D METHODS 
S ubjects 
T wenty- live fa ir-skinned, normal, paid, informed volunteers who 
were not receiving medication were studied. 
Light Sources 
In t he studies of topical 8-MOP sensit ization, UVA irradiation was 
provided by 2 36-inch fluorescent PUVA tubes (Sylvania) . Pea k emis-
sion is at 355 nm, and the tota l irradiance between 320- 400 nm at 20 
em from t he lamps was 1.65 m W /em", measured with an IL 700 radi-
ometer and UVA detector. Uniformi ty of field was± 10%. 
ln t he studies in which oral 8-MOP was used, t he UVA source was 
a 2500-W xenon arc source (Schoeffel Instruments ) wit h an f/ 1.5 quartz 
condensing lens system. Radiation was fil te red through 6 em of a 7% 
CuSO, and 7% CoSO, aqueous solu t ion, and a Schott WG335 (1 mm) 
fil ter, then projected in a uniform (± 7%) rectangu lar field onto the 
skin using an f/4.0 quartz lens. 
Topical B- MOP Treatment 
T hi rty cubic centimeters of aqueous 8-MOP solu tion (0.003 %) was 
in troduced in to an 8 em-diameter cylinder applied firmly to t he un-
tanned skin on t he lower bac k, and left in place for 15 min . Previous 
studies [13] demonstrated t hat application in this way resulted in a 
plateau of photose nsit ivity lasting approximately 30 min , following 
which photosensitivity declined rapidly and was effectively lost by 6 h. 
T he minimum phototoxic dose (MPD) of UVA was determined by 
administering a geometric series of 10 increasing UVA exposures 0.1-
0.8 J / cm' in 15% increments, to test sites 1 em in diameter and wi thin 
the 8-MOP-treated area, immediate ly afte r application. Sites were 
examined and graded visua lly for response at 48 and 72 h. The MP D 
was ta ken as the smallest dose inducing uniform erythema wit h well-
defi ned margins (1 + erythema) . 
Four fur ther a reas of skin were then t reated wit h 8-MOP solution 
as before, and immediately irradiated wit h either 0.0625, 0.1 25, or 0.25 
times the previously determined MPD, or left unirradiated (Fig 1). The 
sites were then covered with cloth un til reexposure 24, 48, or 72 h late r. 
At this t ime, small sites wi t hin these 4 areas were exposed to graduated 
series of doses in order to determine the addi t ional amount of UVA 
required to induce erythema in t hese areas. The responses induced by 
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the second irradiation were graded 72 h later (96, 120, or 144 h after 
the ini t ial 8-MOP application and irradiation). 
OralS-MOP T reatment 
The MPD was determined for each volunteer by exposure to gra du -
ated UVA doses between 2- 20 J /cm" in a geometric series of 20% 
increments, given 2 h afte r ingestion of 8-MOP (0.6 mg/kg); t he 
responses were graded 48 h later. 
Subjects t hen again received t he same dose of ora l 8-MOP and were 
exposed to 0.1 25, 0.25, and 0.5 t imes the previously determined M PD 
in 2 X 8 em areas of skin on t he lower back 2 h late r. In a separate a rea 
the MPD dete rmination was repeated to confirm t he dose fractions 
given to the 2 X 8 em areas. These areas were then covered. Twenty-
four hou rs late r a graduated series of UV A exposures was given to 
determine t he MPD in t hese previously t reated a reas. The MED 
(minimum erythema dose: t hat dose of UVA inducing uni fo rm e ry-
thema wi th well-defined margins in the absence of 8-MOP, read at 24 
h) was also determined at this t ime by exposures to a previously 
unirradiated a rea. Responses were graded 24 h (MED) and 72 h (MPD ) 
afte r the second exposure. 
R ESULTS 
Topical B-MOP Treatment 
In sites irradiated immedia tely a fter topical psora len ap pli-
catio n , t he mea n M P D was 0. 29 ± 0.11 J /cm' (n = 14). If 
irradiatio n was de layed for 6 h or mo re afte r applica t io n t h e 
MPD was greate r t ha n 20 Jjcm~ in each subject, confirming a 
ra pid decline in photosens it ivity when psoralen is applied top -
ically in t his way, a nd a lso dem onstrating that t he MED of 
U VA wi t h absen ce of p sora len was more than 20 J /cm~ . 
In a reas exposed to 0.25 t imes MPD of U V A immediately 
after topical psora len application , no erythema resulted . R eex-
posure of sma ll s ites wi t hin t his a rea to graduated doses of 
U V A 24 h later showed t hat 1 + e rythem a could be induced by 
1.99 ± 1. 78 J /e m" of U VA, observed 72 h afte r t he secon d 
irradiation (T able I). Prolon ged sens it ivity to U VA was a lso 
induced by a n initia l irradiation of 0.0625 o r 0.1 25 t imes t h e 
M P D of U V A immediat e ly a fter psora len applicatio n. The 
degree of photosens it ivity a t 24 h was dose-re la t ed , t he s m a llest 
ini t ia l irradiation (0.0625 t imes MPD) result ing in least pho-
tosens it ivity (MPD at 24 h a fter first exposure = 6.75 ± 2.4 J / 
em~ ) . In a reas receivin g n o initia l irradiation, n o responses were 
induced by doses up to 20 J /cm 2 given at 24 h . 
Areas reexp osed at 48 o r 72 h a fter t he initial exposure we re 
a lso photose ns it ive (Fig 2) a nd t hi s was aga in re lated to the 
dose of t he ini t ia l irradiation . In sites receiving 0.25 t imes M PD 
immedi ate ly a fter 8-MOP application , a mea n of 3 .07 ± 1.21 
J jcm~ was sufficien t at 48 h to cause 1+ erythem a occurring a 
fur t her 72 h later. 
24~ ~!3~ OR 
72 HOUR 
INTERVAL FIG 1. Experimental sequence. 
TOPICAL 8- MOP 
APPLICA TI ON 
r! , 0625 OR 0, .l/ 'i 
X MPD OF UVA 
0 OR Q, 25 X 
MPD OF UVA GRAD UATED UVA 
EX POSURE S 
172 Hnu~ INTE RVA L 
~ RAOE ERYTHEMA 
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TABLE I. Amou.n.t of UVA in. Jjcm' required to induce I+ erythemc. in sites treated with topical8-MOP and immediately exposed to 0, 0.0625, 
0.125, and 0.25 times MPD of UVA 
0 0.0625 X M PD 0. 125 x M PD 0.25 x MPD 
Immediate (=MPD) 
After 24-h inte rval 
After 48-h interval 
After 72- h interval 
0.29 (n = 14) 
>20 (n = 11) 
>20 
>20 
6.75 ± 2.4 (n = 6) 
7.1 ±6.l(n=4) 
11.36 ± 6.1 (n = 3) 
3.8 ± 2.4 (n = 6) 
4. 15 ± 4.45 (n = 4) 
4. 16 ± 1.24 (n = 3) 
1.99 ± 1.78 (n = 10) 
3.65 ± 4.6 (n = 4) 
3.07 ± 1.21 (n = 3) 
1 6 
1 2 
2 J/cm 
8 
4 
0 . 0~25L---------
0 . 25 
2 4 48 
HOURS 
72 
FIG 2. Amount of UVA resul ting in 1 + erythema in areas treated 
24, 48, or 72 h previously wi th 8-MOP and 0.0625, 0.125, or 0.25 times 
MPD of UV A, expressed as J /cm2 ± SEM. 
OralS- M OP T reatment 
T h e MPD determined 2 h after 8-MOP ingestion was 10.6 ± 
3.9 J/cm~ (n = 14). The mean MED of UVA 16 h or 24 h after 
8-MOP ingestion in previously unexposed sites was 90.4 ± 21.7 
J j cm 2 . In t hese subjects t his refl ected t he absence of any 
psor a len-induced UVA sensit ivity 16 h afte r ingestion . 
In a site (2 X 8 em) exposed to 0.5 t imes MPD of UVA 2 h 
afte r ingestion of ora l 8-MOP, no erythema was noted at 24, 
48, o r 72 h. In small sites (1 em diameter) wi t hin this a rea 
reexp osed to graduated doses of UV A 24 h afte r t he ini t ia l 
exposure, e rythema was induced by 56.5 ± 13 J jcm' of UVA 
(Table II). This is significantly less t han the MED of UV A ( p 
< 0.01). S ignificant prolonged photosens it ivity was a lso induced 
by s m a ller dose fractions (0.125 or 0.25 t imes MPD) 2 h afte r 
8-MOP ingestion, detectable by reexposure at 24 h. 
DISCUSSION 
T h e prolonged UV A photosens it ivi ty of skin caused by ini t ia l 
topica l 8-MOP plus a small suberythemogenic dose of UVA 
was strikin g, dose- related, a nd lasted for several days. S ignifi-
cant prolonged photosensit ivi ty was observed after as li ttle as 
0.0625 t imes MP D (approx imately 15 mJ/cm' ), persisted at 
least 72 h , a nd was proporti onal to t he size of t he ini t ia l MP D 
dose fraction given. It is diffi cul t to explain t his striking effect 
with out invoking t he assumpt ions given above. 
TABLE II. Amount of UVA (J/cm 2) required to induce 1+ erythema in 
sites previously exposed to 0, 0.125, 0.25, or 0.5 times MPD of UVA , 2 
h after ingestion of 8-MOP 
Re- irrad iation after 
24-h interva l (n = 
II ) 
0 M PD 0. 125 x MPD 0.25 x M PD 0.5 x MPD 
90 ± 21.7 67 ± 19 63 ± 24 56.5 ± 13 
Several poss ible explanations for prolonged photosensit ivity 
can , however, be considered: 
1. Sufficient free pso ra len may be present in t he skin at the 
t ime of t he second irradiation to result in an addit ive phototoxic 
effect between the ini t ia l suberythema l exposure and t he second 
irradiat ion . T his is unlikely because t he ini t ia lly unirradiated 
control sites demonstrate t hat no cl inically evident phototox -
icity occurs when a single dose of 20 J/cm2 is given 6 h or more 
after psoralen application. 
2. The ini t ial irradiat ion in t he presence of psoralen may 
resul t in "suberythemal da mage" which may be addi t ive to t he 
damage caused by UV A alone at t he time of t he second irradia-
t ion suffi cient ly to cause e rythema t hereafter. T hi s mechan ism 
appea rs to be minor. T he erythema induced by t he second 
exposure a lways peaks 48- 72 h t hereafter, which is strongly 
suggestive of psoralen phototox icity rather than a response to 
UV A alone. Furthermore, t he UV A doses given in t he second 
irradiation which resulted in erythema are at least an order of 
magnitude sma ller tha n t he UV A MED in t hese same subjects. 
The interact ion between t he first and second exposures give n 
is synergistic, not addi t ive. 
3. DNA a nd other repair mecha nisms could be damaged by 
t he ini t ia l suberythema l irradiation in t he presence of psora len, 
resu lt ing in increased suscept ibili ty to damage by subsequent 
UV A. Al t hough t he t ime course of t he erythema a nd the small 
doses required ma ke t his mechanism somewhat unlikely, it 
remains a possibili ty. 
4. Photobinding of psora len in t he skin by t he ini t ia l ir ra-
diation may resul t in prolonged photosens it ivity to subsequent 
UV A. Our findings are most consistent wit h t his interpretation, 
and it is most probable t hat t he ini t ia l photobinding of psoralen 
is in t he form of DNA-pso ralen monoadducts. Alt hough binding 
to proteins occurs, a nd may be of importa nce in t issues such as 
t he ocula r lens, t he most biologically significant reactions are 
be lieved to occu r wit h DNA. 
ln terstra nd crosslinking in part icula r is beli eved to be im-
porta nt in cuta neous psora len phototox icity, but t he evidence 
is still circumstant ia l a nd controvers ia l. A close correlation 
ex ists between t he DNA crosslinking abili ty of different psor-
a len compounds a nd their relative skin-photosensit izing poten-
t ia l [14,15]. However, t hese psora lens may a lso differ in other 
respects, such as t heir ab ili ty to generate singlet oxygen [1 6). 
Our obse rvations here a re best expla ined if psoralen-DNA 
crosslink ing is indeed t he major event leading to psoralen + 
UVA-induced cutaneous erythema, as fo llows: 
Exposure of 8-MOP-treated skin resul ts in the formation of 
both monoadducts and crosslinks. Suberythemogenic doses of 
UV A cause insuffic ient crosslinks to resul t in erythema, but a 
considerable population of psoralen-DNA monoadducts. T hi s 
is especia lly t rue if t he suberythemogenic exposure occurs 111 
t he presence of high psora len concent rations, for example, after 
topical application of 8-MOP, yielding a greater ratio of mon-
oadducts to cross links during init ia l irradiation. After t he UV A 
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exposure, some of t he remaining monoadducts are able to form 
crosslin ks upon further UV exposure. Subsequent crosslinking 
of a sufficient number of monoadducts by a second irradiation 
would result in erythema fo llowing the normal time course for 
psoralen phototoxicity relative to the second UV exposure. 
In our study, erythema following a t ime course typical of 
psoralen phototoxicity could be induced up to 3 days after an 
initia l t reatment with topical 8-MOP followed immediately by 
sma ll doses (20-80 mJ/cm2 ) of UVA. The photosensitivity was 
dose-related with respect to the initial suberythemogenic irra-
diation which formed the monoadduct "substrate." 
Persistence of sensitivity for up to 3 days fo llowing topical 
treatment indicates that unrepaired monoadducts are sti ll pre-
sent. If t he decline in cutaneous photosensitivity with time is 
due to repai r, studying the time course of the induced persistent 
photosensitivity might be of value as an indirect in vivo ap-
proach to t he study of monoadduct repair kinetics. 
The marked difference in photosensitivity observed when 
top ical vs oral sensitization routes are compared can also be 
examined in view of this hypothesis. When psoralen was given 
orally in this study, the MPD was approximately 36-fold greater 
than after topical app lication. Since it may be ca lculated that 
t he ratio of the number of monoadducts formed concomitantly 
with a given number of crosslin ks under different exposure 
condi t ions is approximately the reciproca l of the ratio of the 
MPDs, t his logically accounts for the striking difference in 
persistence of photosensitivity following ora l and topical routes. 
If it is true that about the same number of crosslinks result in 
erythema whatever .route of admin istration is employed, then 
the number of monoadducts produced during exposures of 1 
MPD is much greater with low UV doses and high drug con-
centration (topical) than with high UV doses and low drug 
concentration (oral). 
The induced persistent photosensitive state could account 
for t he prev iously reported "unpredictable behavior" frequently 
seen in skin treated with topical psoralens in clinical settings. 
Burning and blistering which is often a complication of treat-
ment may not be the result of the initial controlled light 
exposure, but of subsequent so lar UV A exposure over the 
ensu ing days, not merely hours. Our data and hypothesis indi-
cate that t hi s wou ld be minimized with oral sensitization, since 
only a minor reduction in the amount of UV A required to 
induce erythema was observed 24 h after initial treatment. 
Whether the persistent photosensitive state cou ld be of clin-
ica l use depends upon several factors . Split irradiation could be 
used to maximize the crosslink to monoadduct ratio. However, 
the biologic lesion induced by PUV A that is effective in pho-
toc hemotherapy remains to be established, as do the relative 
mutagenicities of pso ralen -DNA monoadducts and crosslinks. 
If crosslinks ca n be shown to be relatively more therapeutic 
and less mutagenic than the monoadduct as suggested by m 
vi t ro studies [9), this may be worthy of clinical exploration. 
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